NCT03190304View on ClinicalTrials.gov

The Effect of Neprilysin (LCZ696) on Exercise Tolerance in Patients With Heart Failure

PHASE4CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

June 14, 2017

Primary Completion Date

September 14, 2020

Study Completion Date

September 23, 2020

Conditions
Heart FailureExercise ToleranceVasodilationBody CompositionMuscle Strength
Interventions
DRUG

Neprilysin

To compare the effect of Enalapril and Neprilysin on exercise tolerance in patients with heart failure

DRUG

Enalapril

To compare the effect of Enalapril and Neprilysin on exercise tolerance in patients with heart failure

Trial Locations (1)

05403-900

Marcelo Rodrigues dos Santos, São Paulo

All Listed Sponsors
lead

University of Sao Paulo General Hospital

OTHER

NCT03190304 - The Effect of Neprilysin (LCZ696) on Exercise Tolerance in Patients With Heart Failure | Biotech Hunter | Biotech Hunter